Association of N-acetyltransferase 2 and cytochrome P450 2E1 gene polymorphisms with antituberculosis drug-induced hepatotoxicity in Western India.
about
Arylamine N-acetyltransferases: from drug metabolism and pharmacogenetics to drug discoveryPharmGKB summary: very important pharmacogene information for N-acetyltransferase 2Isoniazid metabolism and hepatotoxicityPharmacogenetics of isoniazid-induced hepatotoxicity.Hepatotoxicity during Treatment for Tuberculosis in People Living with HIV/AIDS.Clinically relevant genetic variants of drug-metabolizing enzyme and transporter genes detected in Thai children and adolescents with autism spectrum disorder.Role of CYP3A in isoniazid metabolism in vivoDrug-induced liver injury: what was new in 2013?Mechanisms of isoniazid-induced idiosyncratic liver injury: emerging role of mitochondrial stress.Update meta-analysis of the CYP2E1 RsaI/PstI and DraI polymorphisms and risk of antituberculosis drug-induced hepatotoxicity: evidence from 26 studies.PharmGKB summary: isoniazid pathway, pharmacokinetics.Association and clinical utility of NAT2 in the prediction of isoniazid-induced liver injury in Singaporean patients.N-acetyltransferase 2, cytochrome P4502E1 and glutathione S-transferase genotypes in antitubercular treatment-induced hepatotoxicity in North Indians.Deficiency of N-acetyltransferase increases the interactions of isoniazid with endobiotics in mouse liver.Susceptibility of N-acetyltransferase 2 slow acetylators to antituberculosis drug-induced liver injury: a meta-analysis.N-acetyltransferase 2 (NAT2) genotype as a risk factor for development of drug-induced liver injury relating to antituberculosis drug treatment in a mixed-ethnicity patient group
P2860
Q26995125-472EDF76-289B-45F3-AD08-61094897922BQ27011622-084F2A68-4E8E-45AB-9A0E-73504C5242A6Q28076859-13E9BCE6-0EDA-41FB-9C0A-8924EDB91AD7Q35669887-95D06CB4-76BD-4F4C-BF24-6147207A045AQ36058879-2D5FBC3D-F10E-4676-A49D-BD6D80897B91Q36808178-10CC2823-C605-44DC-AF82-ADD120513918Q37732312-29466E31-DCE1-4CA9-BD11-28BC6E3559A8Q38205591-E4612BBC-EF08-40C3-89C6-9445E661EAD6Q38208324-C047093D-C229-4EDE-9357-0436710B059FQ38381479-E0D4132B-3333-4283-A59C-673DB1F1BA73Q42090708-4D62F5A9-2AD6-419C-BF50-44F4C64C86B0Q42696912-A5FC7E88-79F8-420F-9F76-911DD703CC77Q45766101-40CCC440-358F-46DF-B80D-D3FCE6D658CBQ47828041-6F4D2DCF-D239-405B-B2EE-845B6E041378Q51569750-DCCF805D-D0E7-40AF-8EF1-EC5094E1B578Q57302643-8FEF4680-FDC0-45C7-AECF-E9F9A6906616
P2860
Association of N-acetyltransferase 2 and cytochrome P450 2E1 gene polymorphisms with antituberculosis drug-induced hepatotoxicity in Western India.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh-hant
name
Association of N-acetyltransfe ...... patotoxicity in Western India.
@en
Association of N-acetyltransfe ...... patotoxicity in Western India.
@nl
type
label
Association of N-acetyltransfe ...... patotoxicity in Western India.
@en
Association of N-acetyltransfe ...... patotoxicity in Western India.
@nl
prefLabel
Association of N-acetyltransfe ...... patotoxicity in Western India.
@en
Association of N-acetyltransfe ...... patotoxicity in Western India.
@nl
P2093
P2860
P356
P1476
Association of N-acetyltransfe ...... patotoxicity in Western India.
@en
P2093
Anjali D Amarapurkar
Deepak N Amarapurkar
Jyotsna M Joshi
Kalpana Joshi
Meenakshi Singh
Pramod P Wangikar
Praveenkumar H Ramegowda
Preetha Sasi
Rajiv Baijal
Vinod H Gupta
P2860
P304
P356
10.1111/JGH.12194
P577
2013-08-01T00:00:00Z